BEIJING – With a focus on efficacy testing for many global pharmaceutical companies, Crown Bioscience has quietly built up the largest patient-derived xenograft (PDX) database anywhere, comprising 2
BeiGene is on a roll. The company’s lead product entered the clinic last December, and the company recently announced the addition of Ronald Levy to its scientific advisory board. Levy is the former c
PharmAsia News brings you a series of profiles on small companies in China. In the last profile, Shenogen Pharma Group Chief Business Officer Jun Bao talked about discovery and development of smal
Exhibit 1 Top Alliances In March 2012 *Potential Deal Value is the sum of up-front fees plus pre-commercialization money. Elsevier’s Strategic Transactions Exhibit 2 Top Mergers & Acquisition In March